Checkpoint Therapeutics Receives Approval for PD-L1 Therapy December 16, 2024 The approval of cosibelimab-ipdl provides an option for patients with cutaneous squamous cell carcinoma December 13, 2024 (Sacramento, California) The…
A Brief History of Mohs Surgery September 16, 2024 The widely used technique for removing nonmelanoma skin cancers, Mohs micrographic surgery, began in a small lab in Wisconsin during…
Jun. 10, 2026 The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 03, 2026 Why Are Young People Tanning Again? What a New allure Feature Reveals About Melanoma Prevention Challenges
Apr. 23, 2026 SkylineDx to Present Data on Precision Molecular Diagnostics Advances in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress
Oct. 08, 2025 Regeneron Announces Approval of Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous-Cell Carcinoma with a High Risk of Recurrence After Surgery and Radiation